2. Roundtable Objectives

The key objective was to understand the processes involved in developing capabilities in Africa for DS manufacturing in more detail, and secondly how to create localisation opportunities for both manufacturing and non-manufacturing countries in Africa to contribute towards the development of regional value chains through the provision of either essential goods or services required.

Specific questions posed to the panellists during the roundtable focused on the following areas: 1. Creating an understanding of the DS production process? 2. Should Africa be pursuing developing DS manufacturing capacity? How will this be beneficial? 3. How the production of vaccines is different from traditional pharmaceutical manufacturing? 4. Manufacturing equipment required and what it takes to move from active ingredients to scale-up of production? 5. How DS manufacturing processes are interlinked and how these processes can be optimized to ensure seamless vaccine production and delivery? 6. Large scale vaccine manufacturing projects in Africa and how plants/facilities are developed? 7. Country vaccine manufacturing plans –

Morocco and Senegal.